During Wednesday’s Current trade, Shares of NCR Corporation (NYSE:NCR), lost -2.33% to $26.79.
NCR Corporation ( NCR), the global leader in consumer transaction technologies, has been named among America’s most reputable companies in the technology industry, according to a new list released by Reputation Institute. NCR ranked #7 overall on the 2015 list of America’s top 25 most reputable technology companies, ahead of some of the most recognizable brands in the world.
Compiled annually by Reputation Institute, the world’s foremost research and advisory firm focused solely on corporate reputations, the list of America’s top 25 most reputable technology companies is derived from the data collected for the US RepTrak® 100 study.
The 2015 US RepTrak® 100 examines perceptions of companies by the US general public based on over 50,000 interviews. Reputation Institute’s RepTrak® model is the gold standard for reputation measurement, providing a one-of-a-kind measurement of how the public views the world’s best-known companies. The RepTrak® database is normative, examining 15 stakeholder groups in more than 25 industries and more than 50 countries for more than 7,000 companies.
NCR Corporation, a technology company, provides solutions and services that enable businesses to connect, interact, and transact with their customers worldwide. The company operates through four segments: Financial Services, Retail Solutions, Hospitality, and Emerging Industries.
Shares of Ubiquiti Netoperates Inc (NASDAQ:UBNT), declined -2.75% to $33.97, during its current trading session.
Ubiquiti Netoperates, Inc. (UBNT) declared results for the fourth fiscal quarter of 2015, ended June 30, 2015.
Fourth Quarter Financial Summary
- Revenues of $145.3 million
- GAAP gross profit of $66.1 million and non-GAAP gross profit of $66.3 million
- GAAP net income of $4.5 million and non-GAAP net income of $44.1 million
- GAAP diluted EPS of $0.05 and non-GAAP diluted EPS of $0.50
Recent Financial Highlights
- Enterprise Technology revenues raised over 26% year-over-year, fueled by UniFi(R)access points and other industry-leading products targeting the Enterprise market
- Initiated a new stock repurchase program, authorizing the Company to repurchase up to $100 million of its common stock as revealed in the Form 8-K filed on August 6, 2015
- Shipped in volume our new Enterprise products, counting UniFi Video products, the UniFi Switch and our newly released EdgeRouterTMX and EdgeRouterTM X SFP
Ubiquiti Netoperates, Inc., together with its auxiliaries, provides various networking products and solutions for service providers and enterprises in the United States and internationally. The company’s service provider product platforms provide carrier-class network infrastructure for fixed wireless broadband, wireless backhaul systems, and routing; and enterprise product platforms provide wireless LAN infrastructure, video surveillance products, and machine-to-machine communication components.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI), during its Wednesday’s current trading session decreased -1.78% to $6.62.
BioDelivery Sciences International, Inc. (BDSI) declared the approval by the U.S. Food and Drug Administration (FDA) of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS® (fentanyl buccal soluble film) CII for the administration of breakthrough pain in patients with cancer who are opioid tolerant. The new formulation was presented to address formerly declared appearance-related changes.
Early this year, BDSI declared that it reached an assignment and revenue sharing agreement with its partner for ONSOLIS, Meda Pharmaceuticals, to return the marketing authorization back to BDSI and the right to seek marketing authorizations for ONSOLIS in the United States, Canada and Mexico. Meda retains the rights to ONSOLIS outside the U.S., where it is marketed in the E.U. as BREAKYL. ONSOLIS is separately licensed by BDSI in Taiwan and South Korea.
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain administration and addiction. The company provides its products based on its patented BioErodible MucoAdhesive (BEMA) drug delivery technology, which comprises of a small, bi-layered erodible polymer film for application to the buccal mucosa.
Finally, RSP Permian Inc (NYSE:RSPP), decreased -6.82%, to $22.01.
RSP Permian, Inc. (RSPP) declared the pricing of an additional $200 million in aggregate principal amount of its 6.625% Senior Notes due 2022 (the “New Notes”) in a private placement to eligible purchasers under Rule 144A and Regulation S of the Securities Act of 1933, as amended (the “Securities Act”). This represents an enhance of $50 million over the aggregate principal amount formerly declared. The New Notes mature October 1, 2022 and were priced at 99.25 percent of the principal amount, with a yield to worst of 6.76 percent. The New Notes are being offered as additional notes to the Company’s existing $500 million aggregate principal amount of 6.625% Senior Notes due 2022 (the “Initial Notes”) that the Company sold in a private placement in September 2014. The New Notes and the Initial Notes will be treated as a single class of debt securities and will have identical terms, other than the issue date.
As formerly declared, the Company has recently closed acquisitions of, or reached definitive purchase agreements to acquire, undeveloped acreage and oil and gas producing properties located in Martin and Glasscock counties for an aggregate purchase price of about $274 million, subject to certain customary purchase price adjustments (the “Martin Glasscock Acquisitions”). The Company intends to use the net proceeds from this offering, together with the proceeds from our formerly declared equity offering, which we estimate at about $157.5 million (before the underwriter’s discounts and commissions and estimated offering expenses), to fund a portion of the purchase price of the Martin Glasscock Acquisitions (counting to repay $50.0 million of borrowings under our revolving credit facility incurred for that purpose) and the remainder for general corporate purposes. The New Notes will be guaranteed on a senior unsecured basis by the Company’s partner, RSP Permian, L.L.C., and certain future auxiliaries.
RSP Permian, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin of West Texas. It owns interest in contiguous acreage blocks in the core of the Midland Basin, a sub-basin of the Permian Basin, primarily in the adjacent counties of Midland, Martin, Andrews, Dawson, Ector, and Glasscock.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
